MedTrace Logo

Composition of Meals Around Exercise Session

NCT04249609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-08-01

No results posted yet for this study

Summary

This will be a randomised cross-over study where participants will be asked to undergo screening session followed by submaximal exercise test and then undergo 2 experimental trials, one high CHO trial and another high fat trial, each lasting over 2 days. On Day 1 participants will consume either high CHO or high fat evening meal and on Day 2 they will be exercising for 60 minutes in the fasted state and then consume either high CHO or high fat morning meal and then 5 hours after morning meal ad libitum buffet meal. After this, they will leave metabolic investigation room and will record all food and drinks consumed during the rest of the day. The washout period between the trials will be at least 7 days. Prior to each of the experimental trials, participants will be asked to avoid consumption of coffee and alcohol for the duration of 2 days. All data collection will all take place in the metabolic research unit at New Lister Building (NLB), Glasgow Royal infirmary (GRI).

Conditions

  • Gastrointestinal Hormones

Interventions

OTHER

HCHO meals and exercise

Exercise will be conducted after high carbohydrate dinner and prior to high carbohydrate breakfast

OTHER

LCHO meals and exercise

Exercise will be conducted after high fat dinner and prior to high fat breakfast

Sponsors & Collaborators

  • University of Glasgow

    lead OTHER

Principal Investigators

  • Dalia Malkova, PhD · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2022-06-02
Completion
2022-08-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04249609 on ClinicalTrials.gov